This in from Cellmid Annual Report
CDY 9:34 AM AGM Presentation by CEO 33
see page 11 especially.
CX Bladder
800k for 2014 and 1m to date???????????????
Printable View
This in from Cellmid Annual Report
CDY 9:34 AM AGM Presentation by CEO 33
see page 11 especially.
CX Bladder
800k for 2014 and 1m to date???????????????
Could you be onto something there?
It may be alot easier to get confirmation information from cellmid (information about PEB sales indirectly)
Reimbursement for over 150millon Americans? 150million sales? That would be hard to believe at this stage
I suppose it could mean that they have reimbursement rights for 150 mil potential sales,
but the fact that they have stated that they have already secured 800k revenue (single digit royalties) certainly makes one wonder.
It certainly brings up questions--how many sales does that represent?
Well, that’s certainly appears at face value to be way ahead of what Cellmid was telling us just last year;
“Cellmid will collect milestone payments and royalties of ~1.5% for an annualised return of $743,000 in the fifth year”
http://www.proactiveinvestors.com.au...013-39465.html
Although, much of that estimated $800k probably comprises milestone payments, still though a positive and encouraging insight.
According to these guys (http://www.rmresearch.com.au/wp-cont.../cellmid-3.pdf) industry standard royalties are 4% which suggests $25m sales to date shich sounds far to high.
Maybe they are including the 1M shares they received in that $1m - what was the shareprice when those shares were issues? (EDIT. cant find when they were issued but first sale was in October 2013 - during October 2013, the price ranged from 50c to $1.49) (Edit 2: The shares were issued in July 2013 http://www.evaluategroup.com/Univers...tory&id=459926 so say an average of 60c = NZ600k which is is ~AUD$530k)
Dont know what it is exactly, perhaps licence fees. Initially I thought 800k divided by 3% of 500.00 gives 53000 tests. Later it says royalties expected late 2014.
Anyone got any clues on this, we need enlightening and quickly.
If it is royalties that 90cents atm seems a tad undervalued.:)
The RM Research on Cxbladder last year, on behalf of Cellmid, estimated royalties to Cellmid in 2014 of $213k, but based on $10M in Cxbladder revenues to Pacific Edge.
http://www.rmresearch.com.au/wp-cont...March-2013.pdf
Thus, of the estimated $800k, either most will probably be milestone payments, or, PEB will be way way ahead of the curve on sales, or it could be a little of both ?
It's really too hard to accurately say without knowing the schedule and magnitude of the milestone payments. Still, it does though seem to be a positive signal even without an ability to fully crunch the numbers.
Revenues vs Royalties.
They both start with R I guess...
Cellmid SP hasn't really moved since the presentation. CxBladder is only one of Cellmid's irons inthe fire, though an important one. The company's CEO was buying up shares on her own account on the open market a couple of weeks ago at about the current level.